姓名：劉淑馨主任
職稱
核子醫學科主任
學歷
中山醫學院醫學士
經歷
‧林口長庚醫院核醫醫學科住院醫師、總醫師
‧花蓮慈濟醫學中心正子造影中心主治醫師
‧核子醫學科專科醫師
現職
‧花蓮慈濟醫學中心核子醫學科主任
‧教育部部定講師
專長
‧核子醫學
‧葡萄糖正子造影
‧腫瘤前哨淋巴結檢查
專科證書
核子醫學科專科醫師
期刊論文(Journal publication)
1. Lue KH, Chen YH*, Chu SC, Chang BS, Lin CB, Chen YC, Lin HH, Liu SH. A comparison of 18F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: a cross-scanner and temporal validation study. Nucl Med Commun. 2023 Sep 21. doi: 10.1097/MNM.0000000000001776. Epub ahead of print.
2. Lue KH*, Chen YH, Wu YF, Liu SH. Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma. Nucl Med Commun. 2023 Jan 1;44(1):74-80.
3. Lue KH, Chu SC, Wang LY, Chen YC, Li MH, Chang BS, Chan SC, Chen YH*, Lin CB, Liu SH. Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma. Ann Nucl Med. 2022 Mar;36(3):256-266.
4. Lue KH, Huang CH, Hsieh TC, Liu SH, Wu YH*, Chen YH*. Systemic Inflammation Index and Tumor Glycolytic Heterogeneity Help Risk Stratify Patients with Advanced Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitor Therapy. Cancers. 2022, 14(2), 309.
5. Chen YH, Chu SC, Wang LY, Wang TF, Lue KH, Lin CB, Chang BS, Liu DW, Liu SH, Chan SC. Prognostic Value of Combing Primary Tumor and Nodal Glycolytic-Volumetric Parameters of 18F-FDG PET in Patients with Non-Small Cell Lung Cancer and Regional Lymph Node Metastasis. Diagnostics (Basel). 2021 Jun 9;11(6):1065.
6. Lue KH, Wu YF, Lin HH, Hsieh TC, Liu SH, Chan SC, Chen YH*. Prognostic Value of Baseline Radiomic Features of 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma. Diagnostics (Basel). 2020 Dec 28;11(1):36.
7. Chen YH, Wang TF, Chu SC, Lin CB, Wang LY, Lue KH, Liu SH, Chan SC. Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma. PLoS One. 2020 Dec 28;15(12):e0244502.
8. Kun-Han Lue, Yi-Feng Wu, Shu-Hsin Liu, Tsung-Cheng Hsieh, Keh-Shih Chuang, Hsin-Hon Lin*, Chen YH*. Intratumour heterogeneity assessed by 18F-FDG PET/CT predicts treatment response and survival outcomes in patients with Hodgkin lymphoma. Acad Radiol. 2020;27(8):e183-e192.
9. Chen YH, Hsu YH, Chen HT, Chang BS, Liu SH. Metastatic Parathyroid Hormone-Secreting Prostate Adenocarcinoma Mimicking Ectopic Parathyroid Adenoma Demonstrated on 99mTc-MIBI Image. Clin Nucl Med. 2020;45(7):555-556.